Published in Infect Immun on August 25, 2014
Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa. MBio (2016) 1.42
The biogeography of polymicrobial infection. Nat Rev Microbiol (2015) 0.96
Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa. J Bacteriol (2015) 0.91
Evolution of metabolic divergence in Pseudomonas aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction. ISME J (2015) 0.84
nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications. mSphere (2017) 0.79
Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus. PLoS One (2015) 0.78
Metabolic modeling of a chronic wound biofilm consortium predicts spatial partitioning of bacterial species. BMC Syst Biol (2016) 0.78
Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells. PLoS One (2015) 0.76
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma. Infect Drug Resist (2016) 0.76
Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections. Appl Microbiol Biotechnol (2016) 0.76
Ecological networking of cystic fibrosis lung infections. NPJ Biofilms Microbiomes (2016) 0.76
Co-evolution with Staphylococcus aureus leads to lipopolysaccharide alterations in Pseudomonas aeruginosa. ISME J (2017) 0.75
Pseudomonas aeruginosa DesB Promotes Staphylococcus aureus Growth Inhibition in Coculture by Controlling the Synthesis of HAQs. PLoS One (2015) 0.75
Copper-Containing Anti-Biofilm Nanofiber Scaffolds as a Wound Dressing Material. PLoS One (2016) 0.75
In vitro Multi-Species Biofilms of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Host Interaction during In vivo Colonization of an Otitis Media Rat Model. Front Cell Infect Microbiol (2017) 0.75
Biofilm models of polymicrobial infection. Future Microbiol (2015) 0.75
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. Front Cell Infect Microbiol (2017) 0.75
Simultaneous and quantitative monitoring of co-cultured Pseudomonas aeruginosa and Staphylococcus aureus with antibiotics on a diffusometric platform. Sci Rep (2017) 0.75
Pseudomonas aeruginosa Alginate Overproduction Promotes Coexistence with Staphylococcus aureus in a Model of Cystic Fibrosis Respiratory Infection. MBio (2017) 0.75
Glycoside Hydrolases Degrade Polymicrobial Bacterial Biofilms in Wounds. Antimicrob Agents Chemother (2016) 0.75
Co-infecting microorganisms dramatically alter pathogen gene essentiality during polymicrobial infection. Nat Microbiol (2017) 0.75
Chromosomal genetics of Pseudomonas. Microbiol Rev (1979) 13.65
The changing epidemiology of cystic fibrosis. J Pediatr (1993) 5.50
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother (1994) 4.87
Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol (2008) 4.30
Biofilms in chronic wounds. Wound Repair Regen (2007) 4.02
The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol Microbiol (2006) 3.43
Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol (2007) 3.22
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett (2007) 3.01
Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol (2005) 2.59
Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen (2008) 2.58
Effect of mixed cultures on antibiotic susceptibility testing. Appl Microbiol (1969) 2.56
Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One (2010) 2.27
The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev (2009) 2.23
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol (2006) 2.08
Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J (2006) 2.07
Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol (2008) 2.05
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.95
Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun (2009) 1.86
Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.78
Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother (2005) 1.73
Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest (2004) 1.72
Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother (2004) 1.70
Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother (2009) 1.68
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis (2005) 1.62
Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J Bacteriol (2005) 1.55
Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol (2009) 1.55
The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol (2013) 1.47
Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun (2007) 1.39
An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One (2011) 1.34
Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One (2013) 1.32
Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One (2011) 1.31
Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol (2008) 1.23
Bacteriological study of diabetic foot infections. J Diabetes Complications (2005) 1.23
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J Antimicrob Chemother (2001) 1.22
Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care (2009) 1.21
3D printing of microscopic bacterial communities. Proc Natl Acad Sci U S A (2013) 1.18
Adhesion mechanisms of staphylococci. Adv Exp Med Biol (2011) 1.18
Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology (2009) 1.15
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia (2010) 1.13
Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med Microbiol Immunol (2012) 1.12
In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen (2009) 1.12
Chronic wounds and the medical biofilm paradigm. J Wound Care (2010) 1.10
Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int Wound J (2013) 1.02
Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care (2010) 1.02
Development of a high-throughput Candida albicans biofilm chip. PLoS One (2011) 1.00
Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J Wound Care (2009) 0.96
Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms. Infect Immun (2013) 0.94
Prevalence of Multiple Antibiotic Resistant Infections in Diabetic versus Nondiabetic Wounds. J Pathog (2014) 0.94
Regulation of the Pseudomonas aeruginosa quorum-sensing regulator VqsR. J Bacteriol (2007) 0.93
Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J Bone Joint Surg Am (2001) 0.93
Effects of staphylolytic enzymes from Pseudomonas aeruginosa on the growth and ultrastructure of Staphylococcus aureus. Microbios (1987) 0.92
Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins. Eur J Clin Microbiol Infect Dis (2011) 0.83
Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading? Br J Biomed Sci (2005) 0.82
Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J Eur Acad Dermatol Venereol (2010) 0.81
Bacterial biofilms in wounds. Wound Repair Regen (2008) 0.78
Action of staphylothrombin on bovine fibrinogen. Thromb Res (1975) 0.77
Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect Immun (2014) 1.00
Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms. Antimicrob Agents Chemother (2016) 0.91
ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Antimicrob Agents Chemother (2015) 0.85
The Spl Serine Proteases Modulate Staphylococcus aureus Protein Production and Virulence in a Rabbit Model of Pneumonia. mSphere (2016) 0.75